However, the degree of CXCL1 mRNA expression was markedly lower in naïve or bacterial-activated BTHS lymphoblasts compared to naïve or bacterial-activated control lymphoblasts, indicating an impaired ability to produce CXCL1 by BTHS patient B lymphoblasts. The gene discussed is CXCL1; the disease is Barth syndrome.